Endobronchial Endometriosis Nd-YAG Therapy vs Drug Therapy
letter
OA: closed
CC0
⤵ 5 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper reports the outcomes of Nd:YAG laser therapy compared to hormonal drug therapy for treating endobronchial endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (6)
- [A patient with pulmonary endometriosis]. via openalex
- Pulmonary endometriosis: conservative treatment with GnRH agonists. via openalex
- Successful Endoscopic Nd-YAG Laser Treatment of Endobronchial Endometriosis via openalex
- Une observation d'endométriose pulmonaire via openalex
- W2037029283 via openalex
- W2408075801 via openalex
Cited by (5)
- Catamenial Hemoptysis: A Case Report and Literature Review 2024
- Photodynamic therapy for treatment of recurrent hemoptysis secondary to pulmonary endometriosis: a case report 2023
- Endometriosis of the lung: A case report and review of literature 2023
- Endometriosis of the Lung: Case Report and Literature Review 2021
- Endometriosis of the lung: case report and literature review 2020
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:15:47.114534+00:00
License: CC0
· commercial use OK